Meihua International Medical Technologies Co Ltd (MHUAF) AI Stock Analysis

49 Followers

Meihua International Medical Technologies Co Ltd

(Other OTC:MHUAF)

Select Model

Rating:58Neutral

Price Target:$6.00▲(3.45% Upside)

Action:downgraded

Date:08/19/26

The overall score is held back primarily by weakening revenues, softer profitability, and highly volatile cash flows, even though the balance sheet remains conservative. Technicals are also negative, with the price below all key moving averages and momentum indicators signaling a continuing downtrend. These weaknesses are partially offset by a very low P/E-based valuation that suggests substantial upside if earnings stabilize, resulting in a slightly below-average overall stock score.

Positive Factors

Low LeverageThe modest debt burden relative to equity gives Meihua financial resilience and flexibility. A conservatively financed balance sheet can reduce interest pressure, support continued operations through weaker demand, and preserve capacity for product development or other business investments.

Negative Factors

Revenue ContractionThe sharp revenue decline shows that the company is currently losing business scale after several years of modest declines from its 2020–2021 peak. If sustained, lower volume would reduce operating leverage, limit reinvestment capacity, and weaken future earnings power.

Meihua International Medical Technologies Co Ltd (MHUAF) vs. SPDR S&P 500 ETF (SPY)

Market Cap: $4.19M
Dividend Yield: ―
Average Volume (3M): 851
Price to Earnings (P/E): 0.4
Beta (1Y): 1.11
Revenue Growth: -36.24%
EPS Growth: -61.74%
Country: US
Employees: 486
Sector: Healthcare
Sector Strength: 51
Industry: Medical - Instruments & Supplies

Meihua International Medical Technologies Co Ltd Business Overview & Revenue Model

Company Description

Meihua International Medical Technologies Co., Ltd. is a Chinese company dedicated to the innovation, production, and distribution of a wide array of medical devices. Operating primarily within the People's Republic of China, its comprehensive produc...

How the Company Makes Money

The company primarily makes money by selling medical devices and medical consumables to healthcare providers and medical supply distributors. Key revenue is generated from (1) product sales of disposable medical supplies (recurring demand driven by s...

Meihua International Medical Technologies Co Ltd Financial Statement Overview

Summary

Financial performance is mixed: the balance sheet is strong with low leverage and rising equity, but revenue and net income have weakened since 2020–2021 and cash generation is volatile, resulting in lower returns on equity and a mid-range overall financial score.

Income Statement

52Neutral

Balance Sheet

72Positive

Cash Flow

40Negative

Financial statement breakdown
Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	61.79M	61.79M	96.91M	97.10M	103.35M	104.04M
Gross Profit	19.08M	18.99M	33.30M	33.09M	38.10M	39.81M
EBITDA	8.83M	8.83M	15.70M	15.77M	11.65M	27.03M
Net Income	6.78M	6.78M	10.84M	11.63M	6.24M	20.95M
Balance Sheet
Total Assets	207.18M	207.18M	186.24M	171.92M	163.58M	136.86M
Cash, Cash Equivalents and Short-Term Investments	15.15M	15.15M	15.96M	16.93M	26.74M	8.15M
Total Debt	8.99M	8.99M	7.95M	7.33M	6.81M	5.18M
Total Liabilities	18.25M	18.25M	27.26M	25.08M	24.90M	29.09M
Stockholders Equity	188.93M	188.93M	158.98M	146.33M	138.12M	106.81M
Cash Flow
Free Cash Flow	554.25K	554.25K	14.50M	-2.41M	-11.86M	-904.89K
Operating Cash Flow	569.88K	569.88K	14.64M	2.28M	-9.16M	-54.66K
Investing Cash Flow	-20.13M	-20.13M	-20.42M	-12.46M	-8.62M	-833.82K
Financing Cash Flow	17.19M	17.19M	6.21M	706.13K	37.25M	1.86M

Meihua International Medical Technologies Co Ltd Technical Analysis

Technical Analysis SentimentNegative

Last Price5.80

Price Trends

50DMA6.77Negative

100DMA7.34Negative

200DMA7.96Negative

Market Momentum

MACD-0.30Positive

RSI28.27Positive

STOCH9.83Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MHUAF, the sentiment is Negative. The current price of 5.80 is below the 20-day moving average (MA) of 6.45, below the 50-day MA of 6.77, and below the 200-day MA of 7.96, indicating a bearish trend. The MACD of -0.30 indicates Positive momentum. The RSI at 28.27 is Positive, neither overbought nor oversold. The STOCH value of 9.83 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for MHUAF.

Meihua International Medical Technologies Co Ltd Risk Analysis

Meihua International Medical Technologies Co Ltd disclosed 80 risk factors in its most recent earnings report. Meihua International Medical Technologies Co Ltd reported the most risks in the "Finance & Corporate" category.

Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

3 New Risks

1.Techniques employed by short sellers may drive down the market price of our Ordinary Shares.Q4, 2023

2.Future sales of our Ordinary Shares, whether by us or our shareholders, could cause our share price to decline.Q4, 2023

3.Raising additional capital and the sale of additional Ordinary Shares or other equity securities could result in dilution to our shareholders, while the incurrence of debt may impose restrictions on our operations.Q4, 2023

Meihua International Medical Technologies Co Ltd Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

MHUAF against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
MHUAF	58Neutral	$4.93M	0.40	3.83%	―	-36.24%	-61.74%
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
WOK	43Neutral	$5.58M	-0.01	-18.55%	―	―	―
LUCY	42Neutral	$7.03M	-0.65	-102.66%	―	56.89%	52.61%
GCTK	38Underperform	$284.19K	-0.00	-2135.52%	―	―	99.51%

* Healthcare Sector Average

Performance Comparison

MHUAF and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
MHUAF	Meihua International Medical Technologies Co., Ltd.	5.80	-17.90	-75.53%
GCTK	Glucotrack, Inc.	0.22	-155.78	-99.86%
LUCY	Innovative Eyewear, Inc.	0.81	-0.80	-49.81%
WOK	WORK Medical Technology Group LTD	1.20	-40898.80	-100.00%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 07, 2026

Meihua International Medical Technologies Co Ltd AI Stock Analysis